1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1583
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8223
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742
|
|
4.
|
Phase: Phase III, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8412
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under 80
Sponsor: NCI
Protocol IDs: CHNMC-IRB-5141, NCI-T85-0105D, T85-0105
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to physiologic 80
Sponsor:
Protocol IDs: NCOG-P-5O851, NCOG-P-5O-85-1
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CLB-8431, CALGB-8431
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-77
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4883, SEG-INT-GU-202
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8371
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-LUN-83208
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: MSKCC-84113, NCI-T84-0476D, T84-0476
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-207
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: CLB-8442, CALGB-8442
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-16832B
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-16834A
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-16834C
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMC-1674, NCI-T83-1415W, T83-1415
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: RPMI-PPC-725, NCI-V85-0099
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: RPMI-PPC-731, NCI-V85-0097
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UKMC-IRB-30295, NCI-T85-0026R, T85-0026
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: RPMI-PPC-727, NCI-V85-0098
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-PPC-829, NCI-V85-0094
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8512, NCI-T85-0126C, T85-0126
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-8536A, NCI-T85-0103C, T85-0103
|
Mobile | Español
